- Substituted piperidines as therapeutic compounds
-
Described are compounds of the general formula (I) and pharmaceutically acceptable salt thereof, in which R2, R3, W,and X have the definitions illustrated in detail in the description, as beta-secretase, cathepsin D, plasmepsin II an
- -
-
-
- Organic compounds
-
The present invention relates to substituted piperidines of the general formula (I), where R1, R2, R3, R4, R5, Q and X have the definitions elucidated in more detail in the description, to a process for their preparation and to the use of these compounds as medicines, in particular as renin inhibitors. Moreover, the enzymatic substrate portion of the compound is simultaneously a substrate for a membrane transporter.
- -
-
Page/Page column 33
(2010/11/30)
-
- NITRATE ESTERS OF PIPERIDINES
-
The application relates to novel nitrate ester derivatives of substituted piperidines of the general formula (I), wherein R1, R2, R3, X, Y and Z0, and m, n, p and q have the meanings explained in more detail in
- -
-
Page/Page column 38; 47
(2008/06/13)
-
- SUBSTITUTED 4-PHENYLPIPERIDINES
-
The application relates to substituted 4-phenylpiperidines of the general formula and their salts, preferably their pharmaceutically acceptable salts, in which R2, R3, W and X have the meanings explained in the description, a process for their preparation and the use of these compounds as medicines, especially as renin inhibitors.
- -
-
Page/Page column 78-79
(2008/06/13)
-